文献速递MDS 与骨髓增殖性肿瘤

511例骨髓增生异常综合征患者靶向基因测序的基因突变特征

[Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2017-01-01

对511例中国骨髓增生异常综合征(MDS)患者行112基因靶向测序并回顾性分析,共检出83个突变基因,439例(86%)伴至少1个突变,最常见为表观遗传相关基因(50%)与剪接子相关基因(37%)。U2AF1突变者单纯+8核型比例增高、复杂核型比例减低,按突变数目分组的三组总生存差异有统计学意义(P=0.041)。

要点

  • 511例MDS中439例(86%)伴至少1个基因突变,共检出83个突变基因。
  • 突变频率依次为表观遗传50%、剪接子37%、信号传导34%、转录因子24%、细胞周期与凋亡17%。
  • 按突变数目0~1个、2个、3个及以上分组,三组总生存差异有统计学意义(P=0.041)。

核心结论

  • 近九成MDS患者伴至少1个基因突变,表观遗传相关基因和剪接子相关基因是MDS最常受累基因。
  • 随着疾病的演进基因突变数增多,基因突变数目多的患者总生存较差。

研究设计与样本

  • 回顾性分析511例中国MDS患者,采用包含112个血液肿瘤相关基因的靶向测序技术检测基因突变并分析临床资料。

主要发现

  • 511例患者中共检测到83个突变基因,439例(86%)伴至少1个基因突变。
  • 突变频率依次为表观遗传相关基因50%、剪接子相关基因37%、信号传导相关基因34%、转录因子24%、细胞周期与凋亡相关基因17%。
  • 各亚型平均基因突变数目为RCUD 1.25个、RCMD 1.73个、RARS 2.79个、RAEB-1 2.22个、RAEB-2 2.34个、MDS伴单纯5q- 2.67个、MDS-U 2.00个。
  • U2AF1突变患者单纯+8核型比例显著增高[Q<0.001,OR=4.42(95% CI 2.23~8.68)],复杂核型比例显著减低[Q=0.005,OR=0.22(95% CI 0.04~0.72)]。
  • 按基因突变数目分为0~1个组、2个组和3个及以上组,三组总生存差异具有统计学意义(P=0.041)。

关键数值与推荐

  • 基因突变频率分类标准:表观遗传相关基因50%、剪接子相关基因37%、信号传导相关基因34%、转录因子24%、细胞周期与凋亡相关基因17%。
  • 亚型平均突变数目:RCUD 1.25个、RCMD 1.73个、RARS 2.79个、RAEB-1 2.22个、RAEB-2 2.34个、MDS伴单纯5q- 2.67个、MDS-U 2.00个。
  • U2AF1突变与单纯+8核型关联:Q<0.001,OR=4.42(95% CI 2.23~8.68)。
  • U2AF1突变与复杂核型关联:Q=0.005,OR=0.22(95% CI 0.04~0.72)。
  • 按突变数目分组的总生存比较:P=0.041。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To study the characteristics of gene mutations in Chinese myelodysplastic syndromes (MDS) patients. Methods: A total of 511 Chinese patients with MDS performed 112-gene targeted sequencing were retrospectively analyzed. Results: Eighty-three distinct mutant genes were found in 511 patients with MDS. Amongst these, the most frequent mutations was associated with epigenetics (50%) , followed by spliceosome (37%) , signal transduction (34%) , transcription factors (24%) and cell cycle/apoptosis (17%) . 439 subjects (86%) had at least one gene mutation. The mean number of mutations in refractory anemia with unilineage dysplasia (RCUD) was 1.25, refractory anemia with multilineage dysplasia (RCMD) was 1.73, refractory anemia with ring sideroblasts (RARS) was 2.79, refractory anemia with excess blasts-1 (RAEB-1) was 2.22, RAEB-2 was 2.34, MDS with isolated 5q- was 2.67, MDS, unclassified (MDS-U) was 2.00. U2AF1 mutant subjects were more likely to have isolated+8[Q<0.001, OR=4.42 (95% CI 2.23-8.68) ]and less likely to have complex karyotypes[Q=0.005, OR=0.22 (95% CI 0.04-0.72) ]. According to the number of gene mutations, all subjects were categorized into three groups, namely group with 0-1 mutation, with 2 mutations and with three or more mutations. There was a significant difference in overall survival (OS) among three groups (P=0.041) . Conclusion: About 90% patients with MDS have at least one gene mutation. Genes associated with epigenetics and spliceosome are most common mutated genes in MDS. The increased numbers of gene mutations accompany with disease evolution and associate with poor prognosis. 目的: 探索中国骨髓增生异常综合征(MDS)患者基因突变特征。 方法: 采用包含112个血液肿瘤相关基因的靶向测序技术对511例MDS患者进行基因突变检测,并回顾性分析其临床资料。 结果: 全部511例MDS患者中,共检测到83个突变基因,439例(86%)患者伴有至少1个基因突变。对涉及的83个基因依据其功能进行分类,突变频率依次为表观遗传相关基因(50%)、剪接子相关基因(37%)、信号传导相关基因(34%)、转录因子(24%)和细胞周期与凋亡相关基因(17%)。不同亚型患者的平均基因突变数目分别为:难治性血细胞减少伴单系发育异常(RCUD)1.25个,难治性血细胞减少伴多系发育异常(RCMD)1.73个,难治性贫血伴环状铁粒幼红细胞(RARS)2.79个,难治性贫血伴原始细胞增多-1(RAEB-1)2.22个,RAEB-2 2.34个,MDS伴单纯5q- 2.67个,MDS未分类(MDS-U)2.00个。U2AF1突变患者单纯+8核型异常比例显著增高[Q<0.001,OR=4.42(95% CI 2.23~8.68)],复杂核型比例显著减低[Q=0.005,OR=0.22(95% CI 0.04~0.72)]。依据基因突变数目,将患者分为伴有0~1个基因突变组,伴有2个基因突变组和伴有3个及以上基因突变组,三组总生存(OS)差异具有统计学意义(P=0.041)。 结论: 近九成的MDS患者伴有至少1个基因突变,表观遗传相关基因和剪接子相关基因是MDS最常受累基因。随着疾病的演进基因突变数增多,基因突变数目多的患者OS较差。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li B, Wang JY, Liu JQ, et al. [Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 29365392. doi:10.3760/cma.j.issn.0253-2727.2017.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。